PortViewPortView
111 logo

111 (YI) Stock Analysis

NASDAQHealthcareMedical - Distribution

$3.31-0.30%
1-year price historyRange $2.56 – $8.38
52-week range$3.31
$2.48$11.17

What 111 does

Based in Shanghai, People's Republic of China, 111, Inc. (established in 2010 and formerly known as New Peak Group until April 2018) is a prominent entity in the Chinese healthcare sector, operating a comprehensive online-to-offline (O2O) ecosystem. Its operations are structured across both business-to-business (B2B) and business-to-consumer (B2C) channels. The company facilitates the sale of a wide array of medical and wellness products, reaching customers through its online retail channels as well as wholesale and retail pharmacy networks. This extensive product catalog encompasses prescription medications, over-the-counter drugs (both Western and traditional Chinese), dietary supplements like vitamins, optical products such as contact lenses, various medical supplies and devices (e.g., bandages, thermometers), personal care items (including skincare, birth control, and sexual wellness products), and infant care essentials. Beyond product sales, 111, Inc. provides value-added services to consumers, such as online consultation and electronic prescription fulfillment. For its business partners, the company manages an online marketplace enabling third-party vendors to directly supply pharmacies. It further supports its "1 Pharmacy" clients – comprising pharmacies and wholesalers – with online loan application services, alongside offering data and supply chain integration solutions. Its operational scope also extends to critical back-end functions, including warehousing, logistics management, procurement, research and development, consulting, as well as software development and IT support. As of December 31, 2021, its physical footprint included 14 retail pharmacies operating under the "Yi Hao Pharmacy" brand across several key regions: Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan. The company caters to a diverse clientele, encompassing individual consumers, pharmacies, pharmaceutical manufacturers and distributors, medical practitioners, and insurance providers.

Key metrics

Market cap
$28.92M
P/E (TTM)
-2.36
EPS (TTM)
$-1.40
Beta
0.67
Dividend yield
0.00%
Revenue / share
$1,290.45
50-day avg
$3.82
200-day avg
$5.11
52-week high
$11.17
52-week low
$2.48
CEO
Junling Liu

ETFs linked to YI

Broad-market and Healthcare sector ETFs an investor holding 111 is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how YI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze YI in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for 111?
111 trades under the ticker YI on NASDAQ.
Which exchange is YI listed on?
YI is listed on NASDAQ.
What sector does 111 operate in?
111 is classified in the Healthcare sector (Medical - Distribution industry).
How can PortView help analyze YI in a portfolio?
PortView shows YI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.